ESR1 and breast cancer: Despite significant efficacy of DIM on breast cancer treatment, Marques et al. [176] recently showed that DIM induced cellular proliferation at concentration of 10 μM by activating estrogen receptor α signaling pathways, in the absence of estradiol, indicating adverse risk of taking DIM as dietary supplement.